glp-1 announcement today CMS Expands Access to Medications for Medicare Beneficiaries GLP-1 Pipeline Update: August 2025

Spironolactone : Reduces androgen-related symptoms like acne and hair growth but does not promote ovulation

Hormonal fluctuations, particularly the drop in estrogen, can impact the nervous system and blood circulation, leading to occasional dizziness or lightheadedness, says Carlson

The World Health Organization (WHO) requested these reviews to help shape upcoming recommendations on using these medications for obesity treatment

We may ask you to provide documentation to prove your identity

However, when a potential side effect becomes as serious as vision loss or blindness, even a remote possibility is worth investigating

Maintaining a healthy weight